Clinical Trial FAQs
Information for patients and study volunteers, including frequently asked questions.
In the study, an extra blood sample is taken during regular blood tests when a pregnant woman is admitted to a Sutter Health hospital to give birth. These samples are stored in the Sutter Health biobank, and will be tested for COVID-19 antibodies.
The goal is to study the spread of COVID-19 in pregnancy and determine if infection rates differ by race, ethnicity, and other factors.
In addition to Alice Pressman, Ph.D., M.S, and Gregory Tranah, Ph.D., Stephen Lockhart, M.D., Ph.D., is also a principal investigator.
Any pregnant woman giving birth at a Sutter Health hospital.
Learn More About the Study. Complete the short form and someone from the study will call you back.
You can also reach the Quality and Health Equity Solutions study team at (800) 524-1440.